Home/Filings/4/0001079973-09-000531
4//SEC Filing

KRALL MICHAEL L 4

Accession 0001079973-09-000531

CIK 0001006028other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 7:10 PM ET

Size

8.2 KB

Accession

0001079973-09-000531

Insider Transaction Report

Form 4
Period: 2009-05-14
KRALL MICHAEL L
DirectorChief Executive Officer
Transactions
  • Award

    Stock Options

    2009-05-14+2,5002,500 total(indirect: See note)
    Exercise: $2.34From: 2010-05-14Exp: 2014-05-14Common Stock (2,500 underlying)
  • Award

    Stock Options

    2009-05-14+200,000200,000 total
    Exercise: $2.34From: 2010-05-14Exp: 2014-05-14Common Stock (200,000 underlying)
Footnotes (2)
  • [F1]Granted pursuant to Pure Bioscience 2007 Equity Compenstion Plan. One-quarter of the options vest each year for four years following the date of grant.
  • [F2]Grant to spouse as an employee. Mr. Krall disclaims beneficial ownership attributed to him.

Issuer

PURE BIOSCIENCE

CIK 0001006028

Entity typeother

Related Parties

1
  • filerCIK 0001053767

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 7:10 PM ET
Size
8.2 KB